Home > Products > Featured products

Piperlongumine

  Cat. No.:  DC9691   Featured
Chemical Structure
20069-09-4
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
Get Quotation Now
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Piperlongumine induces cell death and increases the level of reactive oxygen species (ROS) in cancer cells with both wild-type and normal p53.
Chemicals PropertiesBiological activity COA & MSDSRelated productsDatasheet
Cas No.: 20069-09-4
Chemical Name: Piperlongumine
Synonyms: piperlongumine;(E)-1-(3-(3,4,5-TRIMETHOXYPHENYL)ACRYLOYL)PIPERIDIN-2-ONE;1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one;5,6-Dihydro-1-(1-oxo-3-[3,4,5-trimethoxyphenyl]-trans-2-propenyl)-2[1H]-pyridinone;5,6-Dihydro-1-[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-2(1H)-Pyridinone;Piplartin;Piplartine;5,6-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-trans-2-propenyl]-2(1H)-pyridinone;(E)-1-[3-(3,4,5-Trimethoxyphenyl)acryloyl]-5,6-dihydropyridin-2(1H)-one;5,6-Dihydro-1-(3,4,5-trimethoxycinnamoyl)-2(1H)-pyridone;[ "" ];Piperlongumin;PPLGM;SGD66V4SVJ;VABYUUZNAVQNPG-BQYQJAHWSA-N;(E)-1-(3-(3,4,5-trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one;ST079382;BRD2293;1-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-1,2,5,6-tetrahydropyridin-2-one;(E)-5,6-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-2(1H)-pyridinone;(;PIPERLONGUMINE [MI];1-[(2E)-3-(3,4,5-Trimethoxyphenyl)-2-propenoyl]-5,6-dihydro-2(1H)-pyridinone #;HY-N2329;Piplartine;PPLGM;NSC-794671;EN300-7424497;NCGC00096028-02;CHEBI:92424;Prestwick3_000604;EX-A2925;2(1H)-PYRIDINONE, 5,6-DIHYDRO-1-(1-OXO-3-(3,4,5-TRIMETHOXYPHENYL)-2- PROPENYL)-, (E)-;SPECTRUM1505135;1-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-5,6-dihydropyridin-2(1H)-one;CHEBI:8241;P2361;NCGC00096028-04;CCG-214375;SMR001233252;UNII-SGD66V4SVJ;PIPERLONGUMINE [INCI];BRD-2293;NCGC00096028-01;NCGC00096028-03;1-[3-(3,4,5-Trimethoxy-phenyl)-acryloyl]-5,6-dihydro-1H-pyridin-2-one;2(1H)-Pyridinone, 5,6-dihydro-1-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-, (E)-;LS-14579;s7551;20069-09-4;5,6-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-2(1H)-pyridinone, 9CI;Q7197361;HMS1569J10;FERROUSFLUOBORATE;Piperlongumine, >=97% (HPLC);BRD-K24132293-001-16-0;BRD-K24132293-001-05-3;A1-00162;CHEMBL465843;Prestwick_399;DTXSID801029762;Prestwick2_000604;BSPBio_000508;A920539;Prop-2-en-1-one, 3-(3,4,5-trimethoxyphenyl)-1-(2,3-dihydropyridin-6(1H)-one-1-yl)-;BDBM50462013;AC-32683;2(1H)-Pyridinone, 5,6-dihydro-1-[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-;AKOS024284776;ACon1_001541;N-(3,4,5-Trimethoxycinnamoyl)-D3-piperidin-2-one;J-012992;NSC794671;HMS2234K24;HMS2096J10;MFCD00075706;MLS002153903;BPBio1_000560;Piperlongumine; Piplartine;NCGC00096028-14;CS-0021113;1-[(2E)-3-(3,4,5-Trimethoxyphenyl)-2-propenoyl]-5,6-dihydro-2(1H)-pyridinone;5,6-dihydro-1-[1-oxo-3-(3,4,5-triMethoxyphenyl)-allyl]-2(1H)-pyridinone;SCHEMBL173092;SCHEMBL2465593;SR-01000841248-2;SR-01000841248;BP-25401;5,6-Dihydro-1-(3,4,5-trimethoxycinnamoyl)-2(1H)-pyridinone;BRD-K24132293-001-09-5;AS-74140;BCP13030;"(Z)-piplartine;MLSMR;(E)-piplartine;PIPERLONGUMINE [20069-09-4];NCGC00096028-06;GTPL13376;DA-66744;Piperlongumine?
SMILES: O(C([H])([H])[H])C1C(=C(C([H])=C(C=1[H])/C(/[H])=C(\[H])/C(N1C(C([H])=C([H])C([H])([H])C1([H])[H])=O)=O)OC([H])([H])[H])OC([H])([H])[H]
Formula: C17H19NO5
M.Wt: 317.3365
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Piperlongumine is a natural alkaloid isolated from Piper longum Linn[1], possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities[2]. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines[1]. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway[2].
Target: ERK1 ERK2
In Vivo: Piperlongumine (30 mg/kg/day, i.p. for 3 weeks) exhibits potent anti-tumor effect in athymic nude mice bearing L3.6pL cells without body weight loss[1].
In Vitro: Piplartine (5, 10, and 15 μM) significantly decreases cell proliferation of 786-O, SKBR3, Panc1, A549, and L3.6pL cancer cells after treatment for 24 and 48 hours, induces apoptosis and ROS in these cell lines at 5 and 10 μM after 3 or 9 h of treatment[1]. Piplartine (5 or 10 μM) induces cleaved PARP and downregulates Sp1, Sp3, Sp4, and Sp-regulated genes[1]. Piplartine (20 μM) decreases the viability of cardiac fibroblasts (CFs). Piplartine (0-10 μM) suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway[2].
References: [1]. Karki K, et al. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors. [2]. Wu X, e,t al. Piperlongumine inhibits angiotensin II-induced extracellular matrix expression in cardiac fibroblasts. J Cell Biochem. 2018 Dec;119(12):10358-10364
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC46604 CMD178 CMD178 is a lead peptide that consistently reduced the expression of Foxp3 and STAT5 induced by IL-2/s IL-2Rα signaling. CMD178 also is an inhibitor of STAT5 and inhibit Treg cell development.
DC10139 Stat5 Inhibitor(STAT5-IN-1) Stat5 Inhibitor is a cell permeable nonpetidic nicotinoyl hydrazone which suppresses Stat5 via binding to the SH2 domain.
DC10105 SH5-07 SH5-07 is a hydroxamic acid based Stat3 inhibitor with an IC50 of 3.9±0.6 μM in in vitro assay.
DC7983 SH-4-54 SH-4-54 is a potent STAT inhibitor with KD of 300 nM and 464 nM for STAT3 and STAT5, respectively.
DC9691 Piperlongumine Piperlongumine induces cell death and increases the level of reactive oxygen species (ROS) in cancer cells with both wild-type and normal p53.
DC8474 Napabucasin (BBI608) Napabucasin (BBI608) is an orally-administered small molecule which can block cancer stem cell (CSC) self-renewal and induces cell death in CSCs as well as non-stem cancer cells.
DC10555 inS3-54A18 inS3-54A18 is a potent STAT3 inhibitor, with anti-cancer properties.
DC7751 FLLL32 FLLL32, a novel curcumin analogue, is a potent STAT3 inhibitor.
DC10864 C188-9 C188-9 is a potent inhibitor of STAT3 that binds to STAT3 with high affinity (KD=4.7±0.4 nM). C188-9 is well tolerated in mice, shows good oral bioavailability, and is concentrated in tumors.
DC8040 STAT3 Inhibitor XVIII, BP-1-102 BP-1-102 is a potent, orally bioavailable and selective STAT3 inhibitor.
X
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Site Map|Privacy PolicyCopyright © 2018-2020 All Rights Reserved. Technical Support:KuuJia